Literature DB >> 1320483

Inclusion body myositis: its relative frequency in elderly people.

M L Maat-Schieman1, J D Macfarlane, G T Bots, A R Wintzen.   

Abstract

Inclusion body myositis (IBM) is a distinct, steroid resistant, form of inflammatory myopathy. Its recognition is the more important because of the preponderant occurrence in the elderly, in whom steroid treatment is hazardous. Since the relative frequency of IBM among inflammatory myopathies in the elderly is undetermined, we retrospectively studied its frequency among all our patients over 50 years, diagnosed between 1980 and 1991 with inflammatory myopathy. Nine of 15 patients with inflammatory myopathy appeared to suffer from IBM. In a further 2 patients this diagnosis was strongly suspected. We conclude that IBM is the most frequent inflammatory myopathy in the elderly. This observation warrants restraint with steroids in the management of inflammatory myopathy in the elderly.

Entities:  

Mesh:

Year:  1992        PMID: 1320483     DOI: 10.1016/0303-8467(92)90043-3

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  1 in total

1.  Lower extremity peak force and gait kinematics in individuals with inclusion body myositis.

Authors:  Todd E Davenport; Kimberly Benson; Stephanie Baker; Christopher Gracey; Goran Rakocevic; Beverly McElroy; Marinos Dalakas; Joseph A Shrader; Michael O Harris-Love
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-01       Impact factor: 4.794

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.